| 摘要 |
<p>The present invention relates to a pharmaceutical composition containing ABT-737 and cafestol as active ingredients to prevent or treat cancer. The ABT-737 and cafestol have an excellent anticancer effect against Mcl-1 overexpressed cancer cells by inducing cancer cell-specific apoptosis if being used together, thereby being effectively used for preventing or treating cancer, specifically, kidney cancer.</p> |
